Welcome to our dedicated page for CELESTICA SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CELESTICA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CELESTICA's regulatory disclosures and financial reporting.
Celestica Inc. reported proposed sales of common shares on a Form 144. The filing lists 9,483 common shares tied to restricted share unit vesting dated 12/01/2025 and 7,517 common shares tied to performance share unit vesting dated 02/02/2026. The notice includes form fields showing 17,000, 6,683,040, 114,973,107, and an exchange label NYSE with a date of 06/15/2026.
CLS filed a Form 144 notice disclosing a proposed sale of 140,000 shares of Common Stock by an affiliate, with an aggregate offering price of $56,000,000.00. The filing lists RSU vesting entries of 2,720 (01/31/2020) and 137,280 (02/02/2026). The broker listed is Fidelity Brokerage Services LLC and the market is NYSE.
Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Kulvinder Ahuja reported equity-based compensation awards, not open-market trades. On May 20, 2026, Ahuja received 567 Director Restricted Share Units (D‑RSUs), each representing a right to one common share or equivalent cash and vesting on the first anniversary of the grant date.
On May 19, 2026, Ahuja was also granted 54 Director Share Units, which each represent a contingent right to receive one common share or equivalent cash when the holder ceases serving Celestica as a director, consultant, or other service provider. These awards increase Ahuja’s deferred and restricted share-based holdings but do not involve any purchase or sale of Celestica common shares in the market.
CASCELLA ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Robert Cascella reported new equity-based compensation awards. On May 19, 2026, he was granted 58 Restricted Share Units (RSUs), each representing a contingent right to receive one common share or equivalent cash, with one-third vesting annually over three years.
On May 20, 2026, he received 619 Director Restricted Share Units (D‑RSUs), vesting on the first anniversary of the grant date. Each D‑RSU represents a contingent right to receive one common share upon settlement or an equivalent cash value. These are compensation grants, not open‑market share purchases or sales.
Colpron Francoise reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Francoise Colpron received new equity-based awards in the form of restricted share units. On May 19, 2026, Colpron was granted 115 Restricted Share Units (RSUs), each representing a contingent right to one common share or equivalent cash, vesting in three equal annual installments on each anniversary of the grant date.
On May 20, 2026, Colpron was granted 869 Director Restricted Share Units (D‑RSUs), which vest on the first anniversary of the grant date. Each D‑RSU similarly represents a contingent right to receive one common share upon settlement or, at Celestica’s election, an equivalent value in cash. These grants are compensation awards, not open‑market purchases or sales.
Kale Jill reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc director Jill Kale reported awards of new share-based compensation. On May 19, 2026, she received 108 restricted share units (RSUs), each representing a contingent right to one common share or equivalent cash, with one-third vesting annually over three years.
On May 20, 2026, she was granted 810 director restricted share units (D‑RSUs), which vest on the first anniversary of the grant date. These awards are compensation-related grants, not open‑market purchases or sales of Celestica common shares.
Reeder David reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director David Reeder received equity-based compensation in the form of share units. On May 20, 2026, he was granted 567 Director Restricted Share Units (D-RSUs), each representing a contingent right to receive one common share or cash, vesting on the first anniversary of the grant date.
On May 19, 2026, he was also granted 31 Director Share Units, each representing a contingent right to receive one common share or equivalent cash value when he ceases serving as a director, consultant or other service provider. After these awards, the filing shows holdings of 567 D-RSUs and 31 Director Share Units directly.
Colpitts Christopher W. reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Christopher W. Colpitts received equity-based compensation in the form of director share units. On May 20, 2026, he was granted 810 Director Restricted Share Units (D‑RSUs), each representing a contingent right to one common share or cash, vesting on the first anniversary of the grant date.
On May 19, 2026, he was also granted 108 Director Share Units, each representing a contingent right to receive one common share or an equivalent cash amount when he ceases serving as a director, consultant or other service provider. These are compensation-related awards, not open-market purchases or sales.
Maletira Amar reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Amar Maletira reported equity-based compensation awards, not open-market trades. He received 639 Director Restricted Share Units (D‑RSUs) on May 20, 2026 and 121 Director Share Units on May 19, 2026, both at a price of $0.00 per unit.
Each unit represents a contingent right to receive one Celestica common share or an equivalent cash amount at the company’s discretion. The 639 D‑RSUs vest on the first anniversary of the grant date. Following these grants, Maletira holds 639 D‑RSUs and 1,413 Director Share Units, reflecting ongoing board compensation rather than cash purchases or sales in the market.
KOELLNER LAURETTE T reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Laurette T. Koellner reported awards of share-based compensation units. She received 810 Director Restricted Share Units on May 20, 2026, each representing a contingent right to one common share or equivalent cash and vesting on the first anniversary of the grant date. On May 19, 2026, she was also granted 108 Director Share Units, each tied to one common share or equivalent cash when she ceases serving as a director, consultant or other service provider. These are non-cash, compensation-related grants rather than open-market share purchases or sales.